IL13 and Hodgkins lymphoma: IL-13 is a recognized contributor to the proliferation of certain solid and hematologic malignancies that express its receptor IL-13Ralpha1—such as chronic lymphocytic leukemia and HL [46,47,48]—as well as the decoy receptor IL-13Ralpha2 [49].